
CCL17 - Wikipedia
CCL17 is a powerful chemokine produced in the thymus and by antigen-presenting cells like dendritic cells, macrophages, and monocytes. [5] CCL17 plays a complex role in cancer. It attracts T-regulatory cells allowing for some cancers to evade an immune response. [ 6 ]
CCL17:一种关键的趋化因子及其在免疫系统中的多重角色
2024年4月17日 · 其中,CCL17(也称为TARC)作为一种新的人类CC趋化因子,近年来在生物医学研究中备受关注。 本文将深入探讨CCL17的基本概念、生物功能、在免疫系统中的作用,以及相关的研究进展和临床应用前景。 首先,让我们来了解一下CCL17的基本概念。 CCL17属于C-C趋化因子家族的成员,是一个碱性的94氨基酸残基前体蛋白,通过剪切产生一个71氨基酸残基成熟分泌蛋白。 它主要在胸腺中高水平表达,同时在肺、结肠和小肠中也有低水平表达。 在受刺激 …
趋化因子 CCL17 (CCL17) | 重组蛋白 | MCE - MCE-生物活性 ...
CCL17, also known as thymic and activating regulatory chemokine (TARC), is a powerful chemokine commonly associated with type 2 immune responses, and its encoding gene is located on chromosome 16 in humans.
CCL17 Gene - GeneCards | CCL17 Protein | CCL17 Antibody
2024年12月24日 · CCL17 (C-C Motif Chemokine Ligand 17) is a Protein Coding gene. Diseases associated with CCL17 include Eosinophilic Pneumonia and Paragonimiasis. Among its related pathways are MIF Mediated Glucocorticoid Regulation and TGF-Beta Pathway.
CCL17在肿瘤免疫反应中的研究进展 - 国际免疫学杂志
趋化因子受体(chemokine receptor,CCR)4是CCL17的高亲和力受体,是具有7个跨膜片段的G-蛋白耦联受体。CCL17具有多种生物学功能,参与到炎症、超敏反应、皮肤黏膜疾病、肿瘤、自身免疫性疾病等多个病理生理过程。
CCL17/TARC in autoimmunity and inflammation-not just a T-cell
In this review, we summarize the biology of CCL17, its regulation and its potential contribution to the pathogenesis of various preclinical models. Reference is made, for example, to recent literature indicating a role for CCL17 in the control of pain as part of a granulocyte macrophage-colony-stimulating factor/CCL17 pathway in lymphocyte ...
CCL17 - 药物、适应症、专利 - 智慧芽新药情报库
Natural α-spinasterol is well known for its various biological activities. In this study, we investigated the anti-inflammatory effects of newly synthesized α-spinasterol derivatives by tracking the expression of CCL17 and CCL22 chemokines, which serve as biomarkers for immune cell trafficking in skin inflammation.
The chemokine CCL17 is a novel therapeutic target for ... - Nature
2023年4月19日 · Ccl17 knockout inhibited aging-induced vascular dysfunction. The aortas of young (4-month) and aged (21-month) WT and Ccl17 knockout (Ccl17-KO) male C57BL/6 mice were analyzed.
CCL17/TARC in autoimmunity and inflammation—not just a T‐cell …
2023年3月28日 · CCL17 is elevated in many autoimmune/inflammatory diseases. CCL17, via its cognate receptor, CCR4, is traditionally viewed as a T-cell chemokine with its putative role mainly associated around Th2-driven pathology (e.g. atopic dermatitis and asthma) and Treg-driven pathology (e.g. Hodgkin's lymphoma and cancer metastasis). Recent studies have ...
什么是趋化因子配体17(CCL 17)? - 百家号
2024年5月29日 · CCL17是CC趋化因子家族的小分子量细胞因子,在胸腺高表达,参与免疫平衡和中枢神经系统免疫细胞激活。 它可诱导T细胞趋化,在2型免疫反应和嗜酸性粒细胞相关疾病中起重要作用,还可能参与肿瘤细胞运输,并维持海马小胶质细胞形态。 趋化因子配体17(CCL17)也被称为胸腺活化调节趋化因子(TARC),是CC趋化因子家族的小分子量细胞因子。 CCL17的编码基因在人类中位于第16号染色体上,它与趋化因子受体CCR4相互作用,在调节免疫平衡和 …